Black Diamond Therapeutics Inc (BDTX) — Cash Flow Reinvestment Rate
Black Diamond Therapeutics Inc (BDTX) has a Cash Flow Reinvestment Rate of 0.16x as of March 2025, reinvesting $8.55 Million (capex $0.00 plus investments $8.55 Million) from operating cash flow of $53.41 Million. See BDTX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Black Diamond Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Black Diamond Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Black Diamond Therapeutics Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Black Diamond Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Black Diamond Therapeutics Inc. See financial flexibility index of Black Diamond Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.52x | $44.93 Million | $29.61 Million | $0.00 | — |